nandrolone has been researched along with Drug Withdrawal Symptoms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, JT; Mabey, RG; Mellinger, U; Parke, S; Serrani, M | 1 |
| Macìas, G; Mellinger, U; Merki-Feld, GS; Parke, S; Serrani, M | 1 |
| Carrillo, M; Melloni, RH; Ricci, LA | 1 |
| Castañé, A; Célérier, E; Ghozland, S; Maldonado, R; Nyberg, F; Yazdi, MT | 1 |
| Ivanova, T; Kasakov, L; Pavlova, E; Philipova, T; Vlaskovska, M | 1 |
| Grimes, JM; Melloni, RH; Ricci, LA | 1 |
| Lumia, AR; McGinnis, MY; Possidente, BP | 1 |
2 trial(s) available for nandrolone and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate.
Topics: Adult; Contraceptives, Oral; Double-Blind Method; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Headache; Humans; Menstruation; Nandrolone; Norgestrel; Pelvic Pain; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2013 |
Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
Topics: Adult; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Nandrolone; Pelvic Pain; Substance Withdrawal Syndrome; Young Adult | 2013 |
5 other study(ies) available for nandrolone and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Developmental and withdrawal effects of adolescent AAS exposure on the glutamatergic system in hamsters.
Topics: Adolescent; Aggression; Anabolic Agents; Androgens; Animals; Brain; Cricetinae; Disease Models, Animal; Drug Administration Schedule; Glutamic Acid; Humans; Hypothalamus; Male; Nandrolone; Nandrolone Decanoate; Neurons; Substance Withdrawal Syndrome; Testosterone; Time Factors; Vesicular Glutamate Transport Protein 2 | 2011 |
Effects of nandrolone on acute morphine responses, tolerance and dependence in mice.
Topics: Anabolic Agents; Analgesics, Opioid; Animals; Behavior, Animal; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Tolerance; Male; Mice; Morphine; Morphine Dependence; Motor Activity; Naloxone; Nandrolone; Nociceptors; Pain; Pain Measurement; Reward; Substance Withdrawal Syndrome; Time Factors | 2003 |
Nandrolone modulates the non-opioid and opioid analgesia and tolerance/dependence: role of sexual dimorphism.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Central Nervous System; Dipyrone; Drug Tolerance; Female; Male; Morphine; Nandrolone; Rats; Rats, Wistar; Sexual Behavior, Animal; Substance Withdrawal Syndrome; Substance-Related Disorders | 2003 |
Plasticity in anterior hypothalamic vasopressin correlates with aggression during anabolic-androgenic steroid withdrawal in hamsters.
Topics: Aggression; Anabolic Agents; Animals; Behavior, Animal; Cricetinae; Hypothalamus; Immunohistochemistry; Nandrolone; Neuronal Plasticity; Phenotype; Random Allocation; Substance Withdrawal Syndrome; Testosterone; Vasopressins | 2006 |
Effects of withdrawal from anabolic androgenic steroids on aggression in adult male rats.
Topics: Aggression; Anabolic Agents; Androgens; Animals; Body Weight; Genitalia, Male; Male; Nandrolone; Orchiectomy; Organ Size; Rats; Rats, Long-Evans; Social Dominance; Stanozolol; Substance Withdrawal Syndrome; Testosterone | 2002 |